Sort   by:  
 Page size 
ProteomicsPhosphoproteomic analysis of platelets activated by pro-thrombotic oxidized phospholipids and thrombin
Phosphoproteomic analysis of platelets activated by pro-thrombotic oxidized phospholipids and thrombin Alejandro Zimman, Bjoern Titz, Evangelia Komisopoulou, Sudipta Biswas, Thomas G. Graeber, and Eugene A. Podrez ABSTRACT Specific oxidized phospholipids (oxPCCD36) promote platelet hyper-reactivi...
ORGANISM(S): Homo sapiens (Human) 
2013-12-02 | PXD000451 | Pride
Platelets Ltq-orbitrap Phospho-proteomics Human 
ProteomicsHs_platelets_Phospho_Thrombin
Human platelets Phospho proteome, treated with thrombin
ORGANISM(S): Homo Sapiens (human) 
2014-12-31 | PAe005291 | PeptideAtlas
ProteomicsHs_platelets_Phospho_Control
Human platelets Phospho proteome, control
ORGANISM(S): Homo Sapiens (human) 
2014-12-31 | PAe005287 | PeptideAtlas
ProteomicsHs_platelets_Phospho_PLPC
Human platelets Phospho proteome, treated with PLPC
ORGANISM(S): Homo Sapiens (human) 
2014-12-31 | PAe005239 | PeptideAtlas
ProteomicsHs_platelets_Phospho_KODA-PC
Human platelets Phospho proteome, treated with KODA-PC
ORGANISM(S): Homo Sapiens (human) 
2014-12-31 | PAe005256 | PeptideAtlas
Transcriptomics18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers.
Fluorine-18-fluoro-2-deoxy-D-glucose (FDG) is widely used as positron-emission-tomography (PET) radiotracer for the detection and staging of human cancer. Tumor uptake of FDG varies substantially between different cancer types and between patients with the same tumor type. The molecular basis for th...
ORGANISM(S): Homo sapiens 
2011-11-01 | E-GEOD-21217 | biostudies-arrayexpress
Sort   by:  
 Page size